Jefferies Group LLC Dynavax Technologies Corp Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Jefferies Group LLC holds 6,246 shares of DVAX stock, worth $76,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,246

Previous 490 1174.69%

Holding current value

$76,263

Previous $6,000 983.33%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	BUY	$9.93 - $17.44 $57,157 - $100,384	5,756 Added 1174.69%	6,246 $65,000
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $106,270 - $186,642	10,702 Added 2184.08%	11,192 $68,000
Q2 2022 Sep 21, 2023	SELL	$7.45 - $12.83 $88,334 - $152,125	-11,857 Reduced 96.03%	490 $6,000
Q2 2022 Aug 15, 2022	SELL	$7.45 - $12.83 $272,483 - $469,257	-36,575 Reduced 98.68%	490 $6,000
Q1 2022 Sep 21, 2023	BUY	$9.75 - $14.44 $1,881 - $2,786	193 Added 1.59%	12,347 $133,000
Q1 2022 May 16, 2022	BUY	$9.75 - $14.44 $50,583 - $74,914	5,188 Added 16.28%	37,065 $120,000
Q4 2021 Sep 21, 2023	BUY	$13.17 - $20.94 $9,679 - $15,390	735 Added 6.44%	12,154 $171,000
Q4 2021 Feb 14, 2022	BUY	$13.17 - $20.94 $269,431 - $428,390	20,458 Added 179.16%	31,877 $295,000
Q3 2021 Sep 21, 2023	BUY	$9.16 - $19.83 $13,025 - $28,198	1,422 Added 14.22%	11,419 $219,000
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $13,025 - $28,198	1,422 Added 14.22%	11,419 $219,000
Q2 2021 Sep 21, 2023	BUY	$7.25 - $10.99 $29 - $43	4 Added 0.04%	9,997 $98,000
Q2 2021 Aug 16, 2021	BUY	$7.25 - $10.99 $29 - $43	4 Added 0.04%	9,997 $98,000
Q1 2021 Sep 21, 2023	SELL	$4.57 - $11.18 $5,479 - $13,404	-1,199 Reduced 10.71%	9,993 $98,000
Q1 2021 May 14, 2021	BUY	$4.57 - $11.18 $45,668 - $111,721	9,993 New	9,993 $98,000
Q3 2020 Nov 13, 2020	SELL	$4.32 - $11.7 $38,689 - $104,785	-8,956 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.94 - $9.1 $61,625 - $190,745	-20,961 Reduced 70.06%	8,956 $79,000
Q1 2020 May 15, 2020	SELL	$2.27 - $6.2 $11,538 - $31,514	-5,083 Reduced 14.52%	29,917 $106,000
Q4 2019 Feb 13, 2020	BUY	$3.46 - $6.93 $121,100 - $242,550	35,000 New	35,000 $200,000
Q2 2019 Aug 14, 2019	SELL	$3.65 - $7.89 $47,085 - $101,781	-12,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.08 - $12.09 $19,824 - $33,852	2,800 Added 27.72%	12,900 $94,000
Q4 2018 Feb 14, 2019	SELL	$8.14 - $13.28 $10,818 - $17,649	-1,329 Reduced 11.63%	10,100 $92,000
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $19,256 - $26,000	-1,625 Reduced 12.45%	11,429 $142,000
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $197,768 - $270,870	13,054 New	13,054 $199,000
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $36,625 - $49,750	-2,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $43,250 - $60,199	2,500	2,500 $47,000

Others Institutions Holding DVAX

# of Institutions

273

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Dynavax Technologies Corp Transaction History